
The Curious Case of Teva: Crashing Stock with Hidden Potential
Teva Pharmaceutical Industries offers a diverse portfolio of generic and branded medicines but is navigating a challenging market position. The company’s stock reflects undervaluation despite its robust product pipeline and potential for growth. Teva’s stock performance diverged from overall market trends in